Gene · 7306
Papers3,635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,635
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Membrane compartmentalization of Ect2/Cyk4/Mklp1 and NuMA/dynein regulates cleavage furrow formation. | J Cell Biol | 2022 | 36197340 | PubTator, text mining | PubMed |
| Accelerating skin regeneration and wound healing by controlled ROS from photodynamic treatment. | Inflamm Regen | 2022 | 36192814 | PubTator, text mining | PubMed |
| MicroRNAs: Emerging players in the pathogenesis of vitiligo. | Front Cell Dev Biol | 2022 | 36187493 | PubTator, text mining | PubMed |
| Assessing anxiety during the COVID-19 delta epidemic: Validation of the Chinese coronavirus anxiety scale. | Front Psychol | 2022 | 36186384 | PubTator, text mining | PubMed |
| Induced retinal pigment epithelial cells with anti-epithelial-to-mesenchymal transition ability delay retinal degeneration. | iScience | 2022 | 36185374 | PubTator, text mining | PubMed |
| Type II phosphatidylinositol 4-kinases function sequentially in cargo delivery from early endosomes to melanosomes. | J Cell Biol | 2022 | 36169639 | PubTator, text mining | PubMed |
| Exploration of biomarkers for the diagnosis, treatment and prognosis of cervical cancer: a review. | Discov Oncol | 2022 | 36152065 | PubTator, text mining | PubMed |
| Nomilin from Yuzu Seed Has In Vitro Antioxidant Activity and Downregulates Melanogenesis in B16F10 Melanoma Cells through the PKA/CREB Signaling Pathway. | Antioxidants (Basel) | 2022 | 36139710 | PubTator, text mining | PubMed |
| Advanced Acral Melanoma Therapies: Current Status and Future Directions. | Curr Treat Options Oncol | 2022 | 36125617 | PubTator, text mining | PubMed |
| Complementary and alternative therapies in skin cancer a literature review of biologically active compounds. | Dermatol Ther | 2022 | 36124923 | PubTator, text mining | PubMed |
| Advances in vitiligo: Update on therapeutic targets. | Front Immunol | 2022 | 36119071 | PubTator, text mining | PubMed |
| Family-based exome sequencing identifies candidate genes related to keratoconus in Chinese families. | Front Genet | 2022 | 36118869 | PubTator, text mining | PubMed |
| Simultaneous 9p Deletion and 8p Duplication in a Seven-Year-Old Girl, Detected Using Multiplex Ligation-Dependent Probe Amplification: A Case Report. | Iran J Med Sci | 2022 | 36117579 | PubTator, text mining | PubMed |
| Prolonged, Low-Level Exposure to the Marine Toxin, Domoic Acid, and Measures of Neurotoxicity in Nonhuman Primates. | Environ Health Perspect | 2022 | 36102641 | PubTator, text mining | PubMed |
| Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes. | Cancer Discov | 2022 | 36098958 | PubTator, text mining | PubMed |
| Direct conversion of human umbilical cord mesenchymal stem cells into retinal pigment epithelial cells for treatment of retinal degeneration. | Cell Death Dis | 2022 | 36096985 | PubTator, text mining | PubMed |
| Design, Synthesis, and in Vitro Evaluation of 4-(4-Hydroxyphenyl)piperazine-Based Compounds Targeting Tyrosinase. | ChemMedChem | 2022 | 36093940 | PubTator, text mining | PubMed |
| BCI-215, a Dual-Specificity Phosphatase Inhibitor, Reduces UVB-Induced Pigmentation in Human Skin by Activating Mitogen-Activated Protein Kinase Pathways. | Molecules | 2022 | 36080217 | PubTator, text mining | PubMed |
| Targeted Synthesis and Study of Anti-tyrosinase Activity of 2-Substituted Tetrahydrobenzo[4,5]Thieno[2,3-d]Pyrimidine-4(3H)-One. | Iran J Pharm Res | 2022 | 36060904 | PubTator, text mining | PubMed |
| Thymic self-antigen expression for immune tolerance and surveillance. | Inflamm Regen | 2022 | 36056452 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7306/papers?page=27